Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Project Description:
Datamonitors' SpePharm Holding B.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by SpePharm Holding B.V. since January 2007.
Scope:
– Provides intelligence on SpePharm Holding B.V.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by SpePharm Holding B.V. and its subsidiaries since 2007. – Information about key financial and legal advisors for SpePharm Holding B.V.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Highlights:
This report includes SpePharm Holding B.V.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by SpePharm Holding B.V.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about SpePharm Holding B.V.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
The Europe addictions therapeutics market is expected to reach US$ 2,147.19 million by 2027 from US$ 1,410.85 million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020 to 2027. The growth of the market is attributed to the rising approval of new drugs and launch of digital therapeutics to treat addiction, and increasing...
Online Pharmacy Market Research Report by Type (Non-prescription and Prescription), by Distribution Channel (App only and Online store) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and...
Global Clinical Nutrition Market, By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids,...
The alpha emitter market is expected to witness a healthy CAGR of 36.7% during the forecast period (2020 - 2025). Certain factors that are driving the market growth include increased awareness about the potential benefits of targeted alpha therapy and the growing number of patients with cardiac and cancer ailments. Targeted anticancer...
The global transient protein expression market is expected to reach US$ 983.10 million by 2027 from US$ 660.00 million in 2019. The market is estimated to grow at a CAGR of 5.3% from 2020 to 2027. Increasing applications of protein expression and growing adoption of precision medicines are expected to boost the market growth over the years....
The global human organoids market size is projected to reach USD 1,901 million by 2025 from USD 850 million in 2020, at a CAGR of 17.5%. Factors such as the technological advancements in the market are propelling the growth of the human orgnaoids market. Additionally, rising cases of transplants, investments from both private and public sectors...
The global Vitamin B3 size is estimated to be valued USD 330 million in 2020 and is expected to reach a value of USD 373 million by 2025, growing at a CAGR of 2.5% during the forecast period. Vitamin B3 is an essential micronutrient commercially available in natural and synthetic forms; it is used in pharmaceutical, nutrition, consumer,...
The particle counters market is projected to grow at a CAGR of 9.9% during the forecast period, to reach USD 554million by 2025 from USD 346million in 2020. The growth in thismarket is driven by the robust growth in applied markets, the favorable regulatory scenario, and growing focus on the quality of food products. In addition, emerging...
The chromatography reagents market size is projected to reach USD 7.8 billion by 2025 from an estimated USD 5.5 billion in 2020, at a CAGR of 7.1% during the forecast period. Increasing R&D investments in the pharmaceutical and biotechnology industry is creating demand opportunities for the chromatography reagents industry. Also, increasing...
Global Genetic Disorders Partnering 2014 to 2020 provides the full collection of Genetic Disorders disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Genetic Disorders partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genetic...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.